Literature DB >> 16075052

Weaving betaKlotho into bile acid metabolism.

Antonio Moschetta1, Steven A Kliewer.   

Abstract

Bile acids are natural detergents that assist in the absorption and digestion of fats in the intestine. In liver, the synthesis of bile acids from cholesterol is regulated by multiple signaling cascades that repress transcription of the gene encoding cholesterol 7alpha-hydroxylase (CYP7A1), the rate-limiting enzyme in the classic bile acid synthesis pathway. In this issue of the JCI, Ito and coworkers demonstrate that mice lacking betaKlotho, a membrane protein with 2 putative glycosidase domains, have increased Cyp7a1 mRNA levels and bile acid concentrations. betaKlotho-KO mice also have small gallbladders and are resistant to cholesterol gallstone formation. These findings highlight the central role of betaKlotho in bile acid homeostasis and raise the possibility that this protein could be a pharmacologic target for the treatment of gallstones.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16075052      PMCID: PMC1180565          DOI: 10.1172/JCI26046

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway.

Authors:  S Gupta; R T Stravitz; P Dent; P B Hylemon
Journal:  J Biol Chem       Date:  2001-02-13       Impact factor: 5.157

Review 2.  Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP.

Authors:  Roger A Davis; Jon H Miyake; To Yuen Hui; Nathanael J Spann
Journal:  J Lipid Res       Date:  2002-04       Impact factor: 5.922

3.  Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4.

Authors:  C Yu; F Wang; M Kan; C Jin; R B Jones; M Weinstein; C X Deng; W L McKeehan
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

4.  Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel Klotho family protein.

Authors:  S Ito; S Kinoshita; N Shiraishi; S Nakagawa; S Sekine; T Fujimori; Y I Nabeshima
Journal:  Mech Dev       Date:  2000-11       Impact factor: 1.882

5.  Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

Authors:  C J Sinal; M Tohkin; M Miyata; J M Ward; G Lambert; F J Gonzalez
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

6.  Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho.

Authors:  Shinji Ito; Toshihiko Fujimori; Akiko Furuya; Junko Satoh; Yoko Nabeshima; Yo-Ichi Nabeshima
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 7.  The enzymes, regulation, and genetics of bile acid synthesis.

Authors:  David W Russell
Journal:  Annu Rev Biochem       Date:  2003-01-16       Impact factor: 23.643

8.  Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis.

Authors:  Jason A Holt; Guizhen Luo; Andrew N Billin; John Bisi; Y Yvette McNeill; Karen F Kozarsky; Mary Donahee; Da Yuan Wang; Traci A Mansfield; Steven A Kliewer; Bryan Goodwin; Stacey A Jones
Journal:  Genes Dev       Date:  2003-06-18       Impact factor: 11.361

9.  Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis.

Authors:  Thomas A Kerr; Shigeru Saeki; Manfred Schneider; Karen Schaefer; Sara Berdy; Thadd Redder; Bei Shan; David W Russell; Margrit Schwarz
Journal:  Dev Cell       Date:  2002-06       Impact factor: 12.270

10.  Redundant pathways for negative feedback regulation of bile acid production.

Authors:  Li Wang; Yoon-Kwang Lee; Donnie Bundman; Yunqing Han; Sundararajah Thevananther; Chang Soo Kim; Steven S Chua; Ping Wei; Richard A Heyman; Michael Karin; David D Moore
Journal:  Dev Cell       Date:  2002-06       Impact factor: 12.270

View more
  2 in total

1.  Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation.

Authors:  Galya Vassileva; Andrei Golovko; Lisa Markowitz; Susan J Abbondanzo; Ming Zeng; Shijun Yang; Lizbeth Hoos; Glen Tetzloff; Diane Levitan; Nicholas J Murgolo; Kevin Keane; Harry R Davis; Joseph Hedrick; Eric L Gustafson
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

Review 2.  FGF19 and FGF21 for the Treatment of NASH-Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human.

Authors:  Emma Henriksson; Birgitte Andersen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-22       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.